A new group of hepadnaviruses naturally infecting Orangutans (Pongo pygmaeus) by Warren, K.S. et al.
JOURNAL OF VIROLOGY,
0022-538X/99/$04.0010
Sept. 1999, p. 7860–7865 Vol. 73, No. 9
Copyright © 1999, American Society for Microbiology. All Rights Reserved.
A New Group of Hepadnaviruses Naturally Infecting
Orangutans (Pongo pygmaeus)
KRISTIN S. WARREN,
1,2 JONATHAN L. HEENEY,
3* RALPH A. SWAN,
1 HERIYANTO,
4
AND ERNST J. VERSCHOOR
3
Division of Veterinary and Biomedical Sciences, Murdoch University, Western Australia, Australia
1; Wanariset
Orangutan Reintroduction Centre,
2 and Department of Animal Quarantine,
4 East Kalimantan, Indonesia;
and Department of Virology, Biomedical Primate Research Centre, Rijswijk, The Netherlands
3
Received 21 December 1998/Accepted 14 May 1999
A high prevalence (42.6%) of hepatitis B virus (HBV) infection was suspected in 195 formerly captive
orangutans due to a large number of serum samples which cross-reacted with human HBV antigens. It was
assumed that such viral infections were contracted from humans during captivity. However, two wild orangu-
tans were identiﬁed which were HBV surface antigen positive, indicating that HBV or related viruses may be
occurring naturally in the orangutan populations. Sequence analyses of seven isolates revealed that orangutans
were infected with hepadnaviruses but that these were clearly divergent from the six known human HBV
genotypes and those of other nonhuman hepadnaviruses reported. Phylogenetic analyses revealed geographic
clustering with Southeast Asian genotype C viruses and gibbon ape HBV. This implies a common origin of
infection within this geographic region, with cross-species transmission of hepadnaviruses among hominoids.
Orangutans (Pongo pygmaeus) are the only great apes found
outside Africa. The wild populations are restricted to the is-
lands of Borneo and Sumatra. Orangutans are highly endan-
gered as a result of poaching and the widespread destruction
of their habitats. In an approach to save this great ape from
extinction, orphaned juveniles and conﬁscated pet animals are
housed at centers established to rehabilitate orangutans. In-
creasing human encroachment on rainforest habitat and frag-
mentation of declining populations increases the interactions
and consequently the risks of disease transmission between
wild primates and human populations (16). The accumulation
of relatively solitary orangutans at reintroduction centers also
increases the potential of transmission of viral pathogens, ei-
ther of orangutan or human origin. Due to a high incidence of
morbidity and mortality in these captive animals, concern
arose that certain infectious diseases not found in orangutans
had been acquired from humans.
We recently undertook a serological survey of orangutans to
determine if certain human pathogens may have been trans-
mitted to orangutans. Of the human viruses tested, by far the
most orangutan sera cross-reacted with human hepatitis B
virus (HBV) antigens (15). The distribution of HBV is world-
wide, and there are six different genotypic groups character-
ized to date, designated A to F. Each genomic group has a
characteristic geographic distribution in human populations (7,
12). Group A genomes are found predominantly in northern
Europe and sub-Saharan Africa. Group B and C genomes are
conﬁned to human populations in the Far East. In the Medi-
terranean and the Near and Middle East, group D genomes
are found, while group E is indigenous to West Africa. Group
F has its origins in aboriginal populations of the New World
(10). Because HBV is highly endemic in Southeast Asia (6) and
because of the close contact between humans and captive or-
angutans, it was assumed that these animals were infected with
human HBV. This study aimed to characterize this virus infec-
tion of orangutans in order to determine its origin.
Serum samples were obtained from orangutans (P. pyg-
maeus) that were housed at the Wanariset Orangutan Re-
introduction Center in East Kalimantan, Indonesia. Samples
were assayed for antibodies to HBV core antibody (HBcAb)
and surface antibody (HBsAb), using commercial enzyme-
linked immunosorbent assays (ELISA) (Wellcozyme anti-HBs
and Wellcozyme anti-HBc IgM and IgG kits; Murex Diag-
nostic Ltd., Dartford, United Kingdom). HBV surface antigen
(HBsAg) was detected by using the Murex HBsAg kit (Murex
Diagnostic). All assays were performed according to the man-
ufacturer’s instructions. All serum samples were assayed at
least twice to ensure consistent results.
Serum samples from 195 orangutans were examined for ev-
idence of HBV infection, and multiple samples from different
time points were studied from most individuals. The results
indicated that 42.6% (n 5 83) of the individuals had evidence
of exposure to HBV or a related virus (Table 1). Twenty-eight
animals were surface antibody positive upon arrival, suggesting
a past infection with HBV. Fifty-ﬁve individuals showed evi-
dence of active virus infection, as these were positive in the
HBsAg assay at one or more sampling dates. While housed
at the center, 40 animals converted from HBsAg positive to
HBsAb positive; 15 animals remained HBsAg positive for
longer than 1 year. These orangutans were considered chron-
ically infected. Of these, four individuals had been antigen
positive for more than 4 years and were deﬁned as chronic
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TABLE 1. ELISA and diagnostic PCR screening of orangutan sera
HBV status No. of
individuals
Exposure to HBV (positive in HBsAb and/or HBsAg ELISA) 83
HBsAg-positive individuals 55
HBsAb-positive individuals upon arrival 28
Infected with HBsAg .1 year (chronic carriers) 15
HBsAg positive for .4 years 4
PCR-conﬁrmed viremia 32
7860carriers. New infections at the reintroduction center were doc-
umented in only two instances (14a). Two of three orangutans
which were caught directly from the wild were found to be
HBsAb positive, suggesting infection with an indigenous virus.
Conﬁrmation of infection with an HBV-like virus was ob-
tained by ampliﬁcation of HBV core gene sequences from viral
DNA isolated from sera of HBsAg-positive animals. DNA was
isolated from 100 ml of serum by a modiﬁed RNA isolation
procedure (13). HBV-related sequences were detected using a
diagnostic PCR assay (detection limit, 250 genomes/ml) essen-
tially as described by Zaaijer et al. (17), which ampliﬁed a
521-bp fragment from the HBV core protein gene. The PCR
products were analyzed on a 1.8% agarose gel. Samples from
each individual were examined at least twice in this assay. Of
the 55 HBsAg-positive individuals screened by this assay, 32
were positive by this PCR, conﬁrming infection of these great
apes with an HBV-like virus.
Since sequential serum samples from the animals were not
available, a comprehensive picture of the kinetics of this viral
infection is difﬁcult to piece together. Furthermore, the exact
time point of infection cannot be determined in most cases.
However, the fragmented data available from a number of
animals suggested that this infection and the hosts’ responses
follow trends similar to those observed in HBV-infected hu-
mans (3). Such was the case for one orangutan, Abau, which
acquired infection while at the center. During his stay, four
samples tested negative before the ﬁrst detection of HBsAg in
serum. There was an 8-month period between the last negative
sample and the ﬁrst HBsAg- and PCR-positive serum samples.
Two months later this animal developed HBcAb and HBsAb,
which coincided with the time the serum became HBsAg and
PCR negative (Fig. 1).
To determine if liver pathology was associated with this
infection, serum alanine-aminotransferase (ALT) levels were
examined in the sera of 18 individuals, including 8 chronic
carriers, 4 antibody-positive individuals, and 6 individuals that
were seronegative for HBV. Two to three time points were
evaluated for all chronic carriers, and for two individuals 7 and
9 successive time points were available for testing, respectively.
In all cases, the ALT levels from infected individuals were
within normal limits by comparison with unexposed animals
(10 to 44 U/liter), with one exception (83 U/liter). In the latter
case, this animal was HBV PCR positive and had a record of
being HBsAb negative followed by seroconversion 4 months
later. Furthermore, a liver section obtained from a chronic
carrier (Mojo) that had died of a cause unrelated to HBV
revealed no histological evidence of HBV-related pathology.
Our ﬁndings do not suggest evidence of an overt hepatitis
caused by this infection in these animals. However, only a
limited number of orangutans were tested. Future investiga-
tion using more animals and using samples taken just after
infection are needed to draw a more deﬁnitive conclusion.
To determine if the virus that was detected by serology and
PCR was of human origin, we ampliﬁed and sequenced the S
gene, which is known to be characteristic for the different HBV
genotypes. Oligonucleotide primers hepB-SF1 and BR were
designed to bind to sequences conserved among HBV strains.
Primers hepB-SF1 and BR were used for the ampliﬁcation of
a 1,359-bp DNA fragment encompassing the entire S gene.
FIG. 1. Antibody responses to HBV and detection of viral surface antigen and genomic DNA in sequential serum samples of an orangutan, Abau. Levels of HBsAb
were quantitated and calculated as milliunits per milliliter. Negative and positive results and time points not tested (nt) in HBcAb, HBsAg, and diagnostic PCR assays
are indicated.
TABLE 2. Oligonucleotide primers used for ampliﬁcation and
sequence analysis of the OHV S gene sequence
Primer Sequence (59 to 39) Position
a
hepB-SF1 TGYGGGTCACCWTATTCTTGGG 912–932
hepB-SRin CCTGAGCCTGAGGGCTC 1145–1161
hepB-SRout CACTGTTCCTGAACTGGAGC 1348–1367
BF CTTCTTRTTGGTTCTTCTGG 1712–1731
BR CAYACTTTCCARTCWATAGG 2252–2271
AF CGAVGAYTGGGGACCCTG 1411–1428
AR CCTGGAAKTAGAGGACAAACG 1751–1771
preR AACCCCGCCTGTAACACGAG 1473–1492
a Position on chimpanzee HBV isolate LSH (GenBank accession no. D00220).
VOL. 73, 1999 NOTES 7861PCR was performed in a 50-ml volume, using 10 ml of DNA, 10
mM Tris-HCl (pH 8.3), 50 mM KCl, 0.01% bovine serum
albumin, 50 pmol of each primer, 0.2 mM (each) deoxynucleo-
side triphosphate, 2.5 mM MgCl2,a n d2Uo fAmpliTaqGold
(Perkin Elmer). Samples were preheated for 15 min at 95°C to
activate the enzyme and then cycled for 15 s at 95°C, 15 s at
55°C, and 2 min at 72°C for 30 rounds of ampliﬁcation. The
PCR products were isolated from agarose gel, using a QIA-
quick gel extraction kit (Qiagen, Hilden, Germany), and
cloned in the pGEM-T Easy vector (Promega Corporation,
Madison, Wis.). Sequencing of the cloned insert was per-
formed with pUC/M13 forward and reverse sequencing prim-
ers which bind on either side of the cloned insert and with
HBV-speciﬁc oligonucleotides. Analysis was done on an ABI
PRISM 310 Genetic Analyzer (Perkin Elmer). Primers used
for PCR and sequence analysis and their positions in the chim-
panzee HBV genome are given in Table 2.
We ﬁrst determined the sequence of the entire S gene,
FIG. 2. Alignment of the pre-S protein sequence from seven orangutan isolates with sequences from viruses isolated from gibbon (gibb), chimpanzee (chimp), and
representatives of human HBV genotypes A to F (HBV/A to HBV/F). Identical amino acid residues are marked by a dot, and deletions are indicated by a dash.
TABLE 3. Percentage sequence similarity of HBV SO S gene
with other HBV strains
SO GIBB
a CH
b A
c B
d C
e D
f E
g F
h
SO 100 92.6 90.4 88.4 86.5 88 89.8 87.6 84.1
Gibbon 100 91.8 88.2 86.6 88.6 89.9 88.3 84.6
Chimpanzee 100 89.0 88.2 88.3 92.5 90.6 85.4
A 100 90.9 92.8 88.0 89.8 86.0
B 100 91.0 88.0 88.5 85.4
C 100 88.0 89.3 86.2
D 100 90.7 84.4
E 100 85.3
F 100
a Gibbon HBV (GenBank no. U46935).
b Chimpanzee HBV (GenBank no. D00220).
c Human HBV genotype A (GenBank no. M57663).
d Human HBV genotype B (GenBank no. M54923).
e Human HBV genotype C (GenBank no. X01587).
f Human HBV genotype D (GenBank no. V01460).
g Human HBV genotype E (GenBank no. X75664).
h Human HBV genotype F (GenBank no. X75663).
7862 NOTES J. VIROL.including the pre-S region, of the virus infecting the chronic
carrier Somad (SO). Sequence analysis of the pre-S and S gene
sequences was performed using MacVector 6.0 and Assem-
blyLIGN software packages (Oxford Molecular Ltd.). The nu-
cleotide sequence of the SO isolate showed similarities ranging
from 84.1 to 92.6% with published HBV S gene sequences
(Table 3). The highest degree of similarity was found with
viruses isolated from gibbon (9), chimpanzee (14), and human
HBV genotype D (92.6, 90.4, and 89.8% similarity, respective-
ly). This is primarily due to a 33-bp deletion in the pre-S region
FIG. 3. Alignment of the small S protein of seven orangutan isolates with those from gibbon HBV (gibb), chimpanzee HBV (chimp), and representatives of human
HBV genotypes A to F (HBV/A to HBV/F). Identical amino acid residues are marked by a dot.
VOL. 73, 1999 NOTES 7863that is characteristic of these HBV strains. This feature is
illustrated in Fig. 2 in which the deduced pre-S amino acid
sequence of the SO isolate and six other isolates are aligned
with the same regions of the HBV isolates from chimpanzee,
gibbon, and representatives of all known human genotypes (A
to F). In Fig. 3, the small S proteins of these HBV strains are
compared with those of the orangutan isolates. From Fig. 2
and 3 it is evident that the viruses infecting orangutans are
related to HBV but that they have multiple amino acid resi-
dues which distinguish them from HBV. In the pre-S region
they have three unique amino acid residues (Thr
85, Val/Ser
91,
and Leu/Phe
166), while the small S protein contains six unique
residues (Ser/Leu
5, Leu
56, Val
118, Ser
127, Pro
129, and Ala
224).
Division into genotypes and serotypes is based on speciﬁc
amino acid residues in the small S protein (1, 5, 7, 8, 12). The
hepadnaviruses infecting orangutans thus belong to the ayw or
ayr serotypes, as an arginine (R) residue can be found at
position 122 and a lysine (K) or arginine (R) is at position 160.
However, genotype w1 to w4 subtyping was not possible as the
S proteins contain a unique serine (S) residue at position 127
(Fig. 3). The analysis of nucleotide and amino acid sequences
consistently points to the possibility that orangutans are in-
fected with a hepadnavirus distinct from the known human
HBV types.
Phylogenetic analysis of S gene sequences was performed
using the PHYLIP package, version 3.572 (2). The PHYLIP
FIG. 4. Relationship between OHV with HBV isolated from humans and hepadnaviruses isolated from chimpanzees, gibbons, and woolly monkeys (Woolly). The
tree represents an unrooted consensus tree obtained by the neighbor-joining method based on the nucleotide sequence of the small S protein. Bootstrap analysis was
applied using 100 values. Values on the branches represent the percentage of trees for which the sequences at one end of the branch are a monophyletic group. The
OHV clade as well as the different HBV genotypes and their geographic origins are indicated. The human HBV isolates are identiﬁed by their GenBank database
accession numbers. Accession numbers for chimpanzee and gibbon HBV are described elsewhere. The accession number of the woolly monkey hepadnavirus is
AF046996. Sequence data of OHV isolates described in this article are deposited in the EMBL and GenBank data libraries.
7864 NOTES J. VIROL.program SEQBOOT was used to bootstrap data in which 100
data sets were analyzed. DNAPARS (maximum parsimony)
and NEIGHBOR (neighbor joining) were used to create den-
drograms. CONSENSE was used to create consensus trees
which were visualized using DRAWTREE. In Fig. 4 we have
depicted the results of the neighbor-joining analysis. In this
phylogenetic tree, the orangutan viruses form a cluster sepa-
rated from the six known human HBV genotype clades and
from the chimpanzee and woolly monkey (4) hepadnaviruses.
Formation of a separate orangutan hepadnavirus (OHV) clus-
ter is supported by a high bootstrap value of 100%. Consistent
results were also obtained with maximum parsimony analysis
(data not shown). Closest to the orangutan cluster is the HBV
isolated from gibbons, a primate species that shares habitat
with orangutans. The human genotype C viruses, which also
originate from Southeast Asia, are the human HBV most close-
ly related to the OHVs. This suggests a common ancestor of
hepadnavirus in Southeast Asia that by cross-species transmis-
sion has spread through humans and apes in this geographic
region. The time of divergence between the orangutan viruses
and the human genotype C viruses remains unclear as the rate
of variation of hepadnaviruses in different hominoids is not
exactly deﬁned. However, a recent zoonotic event causing this
hepadnavirus infection in orangutans is highly unlikely. Ogata
et al. (11) report on the transmission of HBV to another great
ape, the chimpanzee. In this comparable situation, no muta-
tions were found in viruses recovered from the chimpanzees
after several rounds of replication in this new host. In addition,
orangutans are solitary animals with limited contact with other
individuals in the wild. This situation may preclude a rapid
spread of viruses among the wild orangutan populations. The
combination of both of these factors argues against a rapid
accumulation of the mutational changes observed in these or-
angutan viruses within their recent natural history.
The data compiled to date reveal that orangutans are in-
fected with a novel hepadnavirus that is distinct but related to
human HBV. In those cases possible to observe, laboratory test
have not revealed evidence of actual hepatitis in animals in-
fected with OHV. However, the impact of OHV on the survival
of existing wild orangutan populations remains to be deter-
mined.
Nucleotide sequence accession numbers. Sequence data of
OHV isolates described in this article are deposited in the
EMBL and GenBank data libraries. The accession numbers
are Y17559, Y17560, Y17561, Y17562, Y17563, Y17564, and
Y17565.
We thank the technicians at the Wanariset Orangutan Reintroduc-
tion Project for assistance in sample collection and the staff of the
Wanariset I Samboja Research Station, especially A. Susilo, W. Smits,
and T. de Kam. Thanks also to the Indonesian Institute for Scientiﬁc
Research for enabling research at the center. The support and tech-
nical assistance of Henk Niphuis, Nel Otting, Natasja de Groot, and
colleagues at the Biomedical Primate Research Centre and the staff at
the Division of Veterinary and Biomedical Sciences, Murdoch Univer-
sity, are greatly appreciated.
We gratefully acknowledge ﬁnancial support provided by BHP Min-
erals, Melbourne, PT Kaltim Prima Coal, CRA Foundation, PT Kelian
Equatorial Mining, and the Merck Foundation.
REFERENCES
1. Blitz, L., F. H. Pujol, P. D. Swenson, L. Porto, R. Atencio, M. Araujo, L.
Costa, D. Callejas-Monsalve, J. R. Torres, H. A. Fields, S. Lambert, C. Van
Geyt, H. Norder, L. O. Magnius, J. M. Echevarria, and L. Stuyver. 1998.
Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians
and other population groups from Venezuela. J Clin. Microbiol. 36:648–651.
2. Felsenstein, J. 1995. PHYLIP: phylogeny inference package, version 3.57.
University of Washington, Seattle, Wash.
3. Hollinger, F. B. 1990. Hepatitis B virus, p. 2171–2236. In B. N. Fields and
D. M. Knipe (ed.), Virology, vol. 2. Raven Press Ltd, New York, N.Y.
4. Lanford, R. E., D. Chavez, K. M. Brasky, R. B. Burns, and R. Rico-Hesse.
1998. Isolation of a hepadnavirus from the woolly monkey, a New World
primate. Proc. Natl. Acad. Sci. USA 95:5757–5761.
5. Magnius, L. O., and H. Norder. 1995. Subtypes, genotypes and molecular
epidemiology of the hepatitis B virus as reﬂected by sequence variability of
the S-gene. Intervirology 38:24–34.
6. Margolis, H. 1993. Prevention of acute and chronic liver disease through
immunisation: hepatitis B and beyond. J. Infect. Dis. 168:9–14.
7. Norder, H., A. M. Courouce, and L. O. Magnius. 1994. Complete genomes,
phylogenetic relatedness, and structural proteins of six strains of the hepatitis
B virus, four of which represent two new genotypes. Virology 198:489–503.
8. Norder, H., A. M. Courouce, and L. O. Magnius. 1992. Molecular basis of
hepatitis B virus serotype variations within the four major subtypes. J. Gen.
Virol. 73:3141–3145.
9. Norder, H., J. W. Ebert, H. A. Fields, I. K. Mushahwar, and L. O. Magnius.
1996. Complete sequencing of a gibbon hepatitis B virus genome reveals a
unique genotype distantly related to the chimpanzee hepatitis B virus. Vi-
rology 218:214–223.
10. Norder, H., B. Hammas, S. Lee, K. Bile, A. M. Courouce, I. K. Mushahwar,
and L. O. Magnius. 1993. Genetic relatedness of hepatitis B viral strains of
diverse geographical origin and natural variations in the primary structure of
the surface antigen. J. Gen. Virol. 74:1341–1348.
11. Ogata, N., R. H. Miller, K. G. Ishak, and R. H. Purcell. 1993. The complete
nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in
fulminant hepatitis and its biological characterization in chimpanzees. Vi-
rology 194:263–276.
12. Okamoto, H., F. Tsuda, H. Sakugawa, R. I. Sastrosoewignjo, M. Imai, Y.
Miyakawa, and M. Mayumi. 1988. Typing hepatitis B virus by homology in
nucleotide sequence: comparison of surface antigen subtypes. J. Gen. Virol.
69:2575–2583.
13. Ten Haaft, P., B. Verstreppen, K. Uberla, B. Rosenwirth, and J. Heeney.
1998. A pathogenic threshold of virus load deﬁned in simian immunodeﬁ-
ciency virus- or simian-human immunodeﬁciency virus-infected macaques.
J. Virol. 72:10281–10285.
14. Vaudin, M., A. J. Wolstenholme, K. N. Tsiquaye, A. J. Zuckerman, and T. J.
Harrison. 1988. The complete nucleotide sequence of the genome of a
hepatitis B virus isolated from a naturally infected chimpanzee. J. Gen.
Virol. 69:1383–1389.
14a.Warren, K. S. Unpublished observations.
15. Warren, K. S., H. Niphuis, Heriyanto, E. J. Verschoor, R. A. Swan, and J. L.
Heeney. 1998. Seroprevalence of speciﬁc viral infections in conﬁscated or-
angutans (Pongo pygmaeus). J. Med. Primatol. 27:33–37.
16. Wolfe, N. D., A. A. Escalant, W. B. Karesh, A. Kilbourn, A. Spielman, and
A. A. Lal. 1998. Wild primate populations in emerging infectious disease
research: the missing link? Emerging Infect. Dis. 4:149–158.
17. Zaaijer, H. L., F. Ter Borg, H. T. M. Cuypers, M. C. A. H. Hermus, and P. N.
Lelie. 1994. Comparison of methods for detection of hepatitis B virus
DNA. J. Clin. Microbiol. 32:2088–2091.
VOL. 73, 1999 NOTES 7865